Magnesium pyridoxal 5-phosphate glutamate: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{drugbox | {{drugbox | ||
| IUPAC_name = | | IUPAC_name = | ||
| Line 25: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
== | |||
'''Magnesium pyridoxal 5-phosphate glutamate''' (trade name '''Sedalipid''') is a [[hypolipidemic agent]].<ref name="pmid11317472">{{cite journal |author=Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ |title=A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting |journal=Eur. J. Clin. Pharmacol. |volume=56 |issue=12 |pages=857-63 |year=2001 |pmid=11317472 |doi=}}</ref> | '''Magnesium pyridoxal 5-phosphate glutamate''' (trade name '''Sedalipid''') is a [[hypolipidemic agent]].<ref name="pmid11317472">{{cite journal |author=Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ |title=A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting |journal=Eur. J. Clin. Pharmacol. |volume=56 |issue=12 |pages=857-63 |year=2001 |pmid=11317472 |doi=}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | |||
{{Lipid modifying agents}} | {{Lipid modifying agents}} | ||
[[Category:Drug]] | |||
[[Category:Cardiovascular Drugs]] | |||
[[Category:Hypolipidemic agents]] | [[Category:Hypolipidemic agents]] | ||
Latest revision as of 17:38, 27 July 2014
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Magnesium pyridoxal 5-phosphate glutamate (trade name Sedalipid) is a hypolipidemic agent.[1]
References
- ↑ Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ (2001). "A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting". Eur. J. Clin. Pharmacol. 56 (12): 857–63. PMID 11317472.
Categories:
- Pages with script errors
- CS1 maint: Multiple names: authors list
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Hypolipidemic agents